Wound Care - Turkey

  • Turkey
  • In Turkey, the revenue in the Wound Care market market reaches US$16.15m in 2024.
  • It is projected to have an annual growth rate of -0.72% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue, amounting to US$1,052.00m in 2024.
  • In terms of per person revenues, US$0.19 is generated in 2024.
  • In Turkey, there is a growing trend in the OTC Pharmaceuticals market for advanced wound care products.

Key regions: Australia, Europe, Canada, United States, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Turkey has been experiencing significant growth in recent years. Customer preferences in the market have shifted towards advanced wound care products, leading to an increase in demand for innovative and technologically advanced solutions. Additionally, the aging population in Turkey has contributed to the growth of the market, as older individuals are more prone to chronic wounds and require specialized wound care.

Customer preferences:
In Turkey, customers have shown a preference for advanced wound care products that promote faster healing and provide better outcomes. This has led to an increased demand for products such as wound dressings, wound closure devices, and negative pressure wound therapy. The market has also witnessed a shift towards disposable wound care products, as they offer better infection control and convenience for patients and healthcare professionals.

Trends in the market:
One of the key trends in the Wound Care market in Turkey is the adoption of innovative technologies. Companies are investing in research and development to introduce new products that incorporate advanced features such as antimicrobial properties, moisture management, and enhanced adherence to the wound bed. These advancements not only improve patient comfort but also accelerate the healing process.Another trend in the market is the rising popularity of home healthcare. With the increasing number of elderly individuals requiring wound care, there is a growing demand for products that can be used at home. This has led to the development of user-friendly wound care solutions that can be easily applied by patients or their caregivers without the need for professional assistance.

Local special circumstances:
Turkey has a large population and a high prevalence of chronic diseases such as diabetes and cardiovascular conditions. These conditions often lead to chronic wounds that require long-term management. As a result, there is a significant need for specialized wound care products and services in the country. The government has also implemented initiatives to improve access to healthcare services, including wound care, which has further contributed to the growth of the market.

Underlying macroeconomic factors:
The growing economy and increasing disposable income in Turkey have also played a role in the development of the Wound Care market. As individuals have more financial resources, they are willing to invest in advanced wound care products that offer better outcomes. Additionally, the government's focus on improving healthcare infrastructure and services has created a favorable environment for the growth of the market.In conclusion, the Wound Care market in Turkey is experiencing growth due to customer preferences for advanced wound care products, the aging population, and the adoption of innovative technologies. The market is expected to continue expanding as the demand for specialized wound care solutions increases and the government continues to invest in healthcare infrastructure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)